{"id":70301,"date":"2026-04-13T16:26:56","date_gmt":"2026-04-13T10:56:56","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=70301"},"modified":"2026-04-13T16:26:57","modified_gmt":"2026-04-13T10:56:57","slug":"dr-reddys-share-price-falls-fda-import-alert","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/dr-reddys-share-price-falls-fda-import-alert\/","title":{"rendered":"Dr Reddy&#8217;s Drops 3.8% After FDA Import Alert on Duvvada Plant \u2014 India&#8217;s Pharma Compounder Hit by Its Own Regulator, Again?"},"content":{"rendered":"<p>Dr Reddy&#8217;s Laboratories \u2014 a prominent Indian listed company \u2014 dropped 3.8% today on a significant news event. At the current valuation, investors are asking whether this correction represents a buying opportunity or the beginning of a more extended decline.<\/p><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here \u2014 Get Free Investment Predictions on Univest<\/strong><\/a>.<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-share-price-falls-fda-import-alert\/#What_Triggered_the_Fall_%E2%80%94_Key_Details\" title=\"What Triggered the Fall \u2014 Key Details\">What Triggered the Fall \u2014 Key Details<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-share-price-falls-fda-import-alert\/#Why_the_Market_Is_Selling_Dr_Reddys_Laboratories_Today\" title=\"Why the Market Is Selling Dr Reddy&#8217;s Laboratories Today\">Why the Market Is Selling Dr Reddy&#8217;s Laboratories Today<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-share-price-falls-fda-import-alert\/#The_Bull_Case_%E2%80%94_Why_This_Sell-Off_May_Be_Overdone\" title=\"The Bull Case \u2014 Why This Sell-Off May Be Overdone\">The Bull Case \u2014 Why This Sell-Off May Be Overdone<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-share-price-falls-fda-import-alert\/#What_Most_Investors_Are_Missing\" title=\"What Most Investors Are Missing\">What Most Investors Are Missing<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-share-price-falls-fda-import-alert\/#Dr_Reddys_Laboratories_Share_Price_Levels_Support_2026_Target\" title=\"Dr Reddy&#8217;s Laboratories Share Price: Levels, Support &amp; 2026 Target\">Dr Reddy&#8217;s Laboratories Share Price: Levels, Support &amp; 2026 Target<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-share-price-falls-fda-import-alert\/#Three_Scenarios_Investors_Are_Pricing_In_Right_Now\" title=\"Three Scenarios Investors Are Pricing In Right Now\">Three Scenarios Investors Are Pricing In Right Now<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-share-price-falls-fda-import-alert\/#Key_Business_Segments_What_to_Watch\" title=\"Key Business Segments &amp; What to Watch\">Key Business Segments &amp; What to Watch<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-share-price-falls-fda-import-alert\/#What_Should_Dr_Reddys_Laboratories_Shareholders_Do_Today\" title=\"What Should Dr Reddy&#8217;s Laboratories Shareholders Do Today?\">What Should Dr Reddy&#8217;s Laboratories Shareholders Do Today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-share-price-falls-fda-import-alert\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-share-price-falls-fda-import-alert\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-share-price-falls-fda-import-alert\/#Q_Why_did_Dr_Reddys_fall\" title=\"Q: Why did Dr Reddy&#8217;s fall?\">Q: Why did Dr Reddy&#8217;s fall?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-share-price-falls-fda-import-alert\/#Q_What_is_an_FDA_import_alert\" title=\"Q: What is an FDA import alert?\">Q: What is an FDA import alert?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-share-price-falls-fda-import-alert\/#Q_Is_Dr_Reddys_a_buy\" title=\"Q: Is Dr Reddy&#8217;s a buy?\">Q: Is Dr Reddy&#8217;s a buy?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-share-price-falls-fda-import-alert\/#Q_What_is_Dr_Reddys_target\" title=\"Q: What is Dr Reddy&#8217;s target?\">Q: What is Dr Reddy&#8217;s target?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-share-price-falls-fda-import-alert\/#Q_What_is_Duvvada_facility\" title=\"Q: What is Duvvada facility?\">Q: What is Duvvada facility?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-share-price-falls-fda-import-alert\/#Q_How_long_do_FDA_import_alerts_last\" title=\"Q: How long do FDA import alerts last?\">Q: How long do FDA import alerts last?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-share-price-falls-fda-import-alert\/#Q_Are_biosimilars_affected\" title=\"Q: Are biosimilars affected?\">Q: Are biosimilars affected?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-share-price-falls-fda-import-alert\/#Q_What_should_investors_do\" title=\"Q: What should investors do?\">Q: What should investors do?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-share-price-falls-fda-import-alert\/#Recent_Articles\" title=\"Recent Articles\">Recent Articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Triggered_the_Fall_%E2%80%94_Key_Details\"><\/span><strong>What Triggered the Fall \u2014 Key Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Parameter<\/strong><\/td><td><strong>Detail<\/strong><\/td><\/tr><tr><td>Trigger<\/td><td>US FDA issued import alert on Duvvada API manufacturing facility<\/td><\/tr><tr><td>CMP<\/td><td>Rs 1,120<\/td><\/tr><tr><td>52-Week High<\/td><td>Rs 1,380<\/td><\/tr><tr><td>52-Week Low<\/td><td>Rs 980<\/td><\/tr><tr><td>Market Cap<\/td><td>Rs 97,000 Cr<\/td><\/tr><tr><td>Trailing P\/E<\/td><td>18xx<\/td><\/tr><tr><td>12M Analyst Target<\/td><td>Rs 1,350\u20131,600<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Why_the_Market_Is_Selling_Dr_Reddys_Laboratories_Today\"><\/span><strong>Why the Market Is Selling Dr Reddy&#8217;s Laboratories Today<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Dr Reddy&#8217;s Duvvada facility manufactures APIs for its US generic formulations. An import alert means US-bound shipments from Duvvada are detained at customs \u2014 halting revenue from this facility immediately. The scale of Duvvada&#8217;s US API contribution is approximately Rs 900\u20131,100 crore annually.<\/p><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Tap to Access Best Research Pieces on Univest<\/strong><\/a>.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"The_Bull_Case_%E2%80%94_Why_This_Sell-Off_May_Be_Overdone\"><\/span><strong>The Bull Case \u2014 Why This Sell-Off May Be Overdone<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Dr Reddy&#8217;s has a 15-year track record of resolving FDA observations \u2014 including a major import alert on its Srikakulam facility in 2015 that was fully resolved by 2017. CEO Erez Israeli&#8217;s track record of regulatory remediation is the strongest in Indian pharma.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Most_Investors_Are_Missing\"><\/span><strong>What Most Investors Are Missing<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Dr Reddy&#8217;s biosimilar portfolio (Rituximab, Bevacizumab, Filgrastim) is manufactured at facilities not affected by the Duvvada alert. US biosimilar revenue \u2014 growing 30%+ annually \u2014 continues without disruption. The market is repricing the stock as if the entire US business is affected, when only Duvvada API shipments are restricted.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Dr_Reddys_Laboratories_Share_Price_Levels_Support_2026_Target\"><\/span><strong>Dr Reddy&#8217;s Laboratories Share Price: Levels, Support &amp; 2026 Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Parameter<\/strong><\/td><td><strong>Value<\/strong><\/td><\/tr><tr><td>CMP<\/td><td>Rs 1,120<\/td><\/tr><tr><td>52W High<\/td><td>Rs 1,380<\/td><\/tr><tr><td>52W Low<\/td><td>Rs 980<\/td><\/tr><tr><td>P\/E<\/td><td>18x<\/td><\/tr><tr><td>12M Target<\/td><td>Rs 1,350\u20131,600<\/td><\/tr><tr><td>Support<\/td><td>Rs 980\u20131,060<\/td><\/tr><tr><td>Mkt Cap<\/td><td>Rs 97,000 Cr<\/td><\/tr><tr><td>NSE Symbol<\/td><td>DRREDDY<\/td><\/tr><tr><td>1Y Return<\/td><td>-10%<\/td><\/tr><tr><td>Resistance<\/td><td>Rs 1,200\u20131,280<\/td><\/tr><\/tbody><\/table><\/figure><p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Dr Reddy&#8217;s Laboratories live.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Three_Scenarios_Investors_Are_Pricing_In_Right_Now\"><\/span><strong>Three Scenarios Investors Are Pricing In Right Now<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Scenario<\/strong><\/td><td><strong>Probability<\/strong><\/td><td><strong>Price Implication<\/strong><\/td><\/tr><tr><td>FDA VAI issued within 90 days; import alert lifted; Duvvada reinstated<\/td><td>Medium<\/td><td>Recovery Rs 1,250\u20131,380; regulatory overhang clears<\/td><\/tr><tr><td>Import alert lasts 12\u201318 months; partial revenue shift to other facilities<\/td><td>Medium-High<\/td><td>Rs 1,050\u20131,200 range; earnings cut 8\u201312%<\/td><\/tr><tr><td>Multiple facility FDA actions; systemic compliance concern emerges<\/td><td>Low<\/td><td>Break Rs 980; sustained institutional selling<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Key_Business_Segments_What_to_Watch\"><\/span><strong>Key Business Segments &amp; What to Watch<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Segment<\/strong><\/td><td><strong>Revenue\/Metric<\/strong><\/td><td><strong>Outlook<\/strong><\/td><\/tr><tr><td>US Generics (excl. biosimilars)<\/td><td>40%<\/td><td>Duvvada impact; other facilities compensating<\/td><\/tr><tr><td>Biosimilars (US + Europe)<\/td><td>18%<\/td><td>Unaffected by Duvvada; growing 30% YoY<\/td><\/tr><tr><td>India Branded Generics<\/td><td>22%<\/td><td>Fully insulated; 12% growth<\/td><\/tr><tr><td>Emerging Markets<\/td><td>12%<\/td><td>CIS, Africa, LatAm; healthy<\/td><\/tr><tr><td>API Sales (Third Party)<\/td><td>8%<\/td><td>Partially Duvvada-affected<\/td><\/tr><\/tbody><\/table><\/figure><p>Track Dr Reddy&#8217;s Laboratories live on the <a href=\"https:\/\/univest.in\/screeners\"><strong>Univest Screener<\/strong><\/a> \u2014 real-time fundamentals, FII\/DII flows, analyst ratings.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Should_Dr_Reddys_Laboratories_Shareholders_Do_Today\"><\/span><strong>What Should Dr Reddy&#8217;s Laboratories Shareholders Do Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Dr Reddy&#8217;s Laboratories at Rs 1,120 \u2014 down 3.8% today \u2014 presents a specific risk-reward question. The 52-week low of Rs 980 is the technical anchor. The trigger event&#8217;s resolution timeline is the key catalyst. Long-term investors should define whether today&#8217;s news changes the fundamental thesis before acting. Traders should use Rs 980 as the stop-loss reference and watch for the specific resolution catalyst identified in this article.<\/p><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Subscribe to Univest Pro for SEBI-registered analyst recommendations on Dr Reddy&#8217;s Laboratories \u2014 entry, stop-loss, and target.<\/strong><\/a><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Dr Reddy&#8217;s Laboratories&#8217;s 3.8% fall on US FDA issued import alert on Duvvada API manufacturing facility is a market event that demands specific analysis \u2014 not reflexive panic or reflexive buying. The bear case is specific: dr reddy&#8217;s duvvada facility manufactures apis for its us generic formulations. The bull case is equally specific: dr reddy&#8217;s has a 15-year track record of resolving fda observations \u2014 including a major import alert on its srikakulam facility in 2015 that was fully resolved by 2017. The 52-week low of Rs 980 is the technical line. The analyst consensus target of Rs 1,350\u20131,600 implies meaningful upside if the bullish scenario plays out.<\/p><p>This article is for informational purposes only. Please conduct your own research and consult a SEBI-registered financial advisor before making any investment decisions.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_Why_did_Dr_Reddys_fall\"><\/span><strong>Q: Why did Dr Reddy&#8217;s fall?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>FDA import alert on Duvvada API facility halts US-bound shipments \u2014 approximately Rs 900\u20131,100 Cr annual revenue affected.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_What_is_an_FDA_import_alert\"><\/span><strong>Q: What is an FDA import alert?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>A designation that automatically detains shipments from a specific facility at US ports of entry, pending corrective action.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_Is_Dr_Reddys_a_buy\"><\/span><strong>Q: Is Dr Reddy&#8217;s a buy?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>This article does not constitute investment advice. At 18x P\/E \u2014 cheapest quality pharma in India \u2014 with biosimilars unaffected, the risk-reward is specific. Consult SEBI-registered advisor.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_What_is_Dr_Reddys_target\"><\/span><strong>Q: What is Dr Reddy&#8217;s target?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Rs 1,350\u20131,600 analyst consensus. At Rs 1,120, 21\u201343% upside. Not guaranteed returns.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_What_is_Duvvada_facility\"><\/span><strong>Q: What is Duvvada facility?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Duvvada (Andhra Pradesh) is one of Dr Reddy&#8217;s largest API manufacturing plants \u2014 producing active pharmaceutical ingredients for US and global generic formulations.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_How_long_do_FDA_import_alerts_last\"><\/span><strong>Q: How long do FDA import alerts last?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Typically 12\u201336 months depending on the severity of observations and speed of corrective action. Dr Reddy&#8217;s Srikakulam alert (2015) was resolved in approximately 18 months.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_Are_biosimilars_affected\"><\/span><strong>Q: Are biosimilars affected?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>No. Biosimilars are manufactured at Hyderabad biologics facilities \u2014 separate from Duvvada API plant. US biosimilar revenue continues uninterrupted.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_What_should_investors_do\"><\/span><strong>Q: What should investors do?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Watch FDA VAI (Voluntary Action Indicated) status for Duvvada \u2014 expected within 90\u2013120 days of re-inspection. Rs 980 is stop-loss. Consult SEBI-registered financial advisor.<\/p><p><strong>Disclaimer: <\/strong>Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Consult a SEBI-registered financial advisor before making any investment decisions.<\/p><p>For more analysis, visit <a href=\"https:\/\/univest.in\/blogs\">Univest Blogs<\/a>.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Articles\"><\/span><strong>Recent Articles<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/why-is-krbl-share-price-falling\"><strong>Why is KRBL Share Price Falling? Check Next Share Price Target&nbsp;<\/strong><\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-is-reliance-infrastructures-share-price-falling\"><strong>Why is Reliance Infrastructures Share Price Falling? Check Next Share Price Target&nbsp;<\/strong><\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-is-mahanagar-gas-share-price-falling\"><strong>Why is Mahanagar Gas Share Price Falling? Check Next Share Price Target&nbsp;<\/strong><\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-is-happiest-minds-share-price-falling\"><strong>Why is Happiest Minds Share Price Falling? Check Next Share Price Target&nbsp;<\/strong><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Dr Reddy&#8217;s Laboratories \u2014 a prominent Indian listed company \u2014 dropped 3.8% today on a significant news event. At the current valuation, investors are asking whether this correction represents a buying opportunity or the beginning of a more extended decline. Click Here \u2014 Get Free Investment Predictions on Univest. What Triggered the Fall \u2014 Key<\/p>\n","protected":false},"author":23,"featured_media":70304,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[4039],"class_list":["post-70301","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-share-price-drops"],"metadata":{"_edit_lock":["1776077874:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"rank_math_primary_category":["842"],"rank_math_seo_score":["82"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"rank_math_title":["Dr Reddy's Drops 3.8% After FDA Import Alert on Duvvada Plant \u2014 India's Pharma Compounder Hit by Its Own Regulator, Again?"],"rank_math_description":[": Dr Reddy's Laboratories share price falls 3.8% \u2014 US FDA issued import alert on Duvvada API manufacturing facility. Full analysis, price support levels, 3 scenarios and what investors should do."],"rank_math_focus_keyword":["Dr Reddy's"],"_thumbnail_id":["70304"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["7942"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/13162449\/Dr-Reddys.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/70301","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=70301"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/70301\/revisions"}],"predecessor-version":[{"id":70307,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/70301\/revisions\/70307"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/70304"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=70301"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=70301"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=70301"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}